Physio-Control said Monday it agreed with the U.S. Food and Drug Administration on a plan to revamp its manufacturing quality-control procedures to comply with federal regulations. The agreement was ...

Medtronic’s Physio-Control Inc. unit indefinitely suspended shipments of external defibrillators and other emergency response gear because of quality control problems at a factory in Redmond, ...

Medtronic Inc. subsidiary Physio-Control is causing its parent company headaches again, this time with a recall of its LifePak 15 monitor/defibrillator. The Food and Drug Administration classified ...

REDMOND, WASH. – Feb. 19, 2010 – Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today it received notice from the U.S. Food and Drug Administration (FDA) that ...

Medtronic Inc. (NYSE:MDT) on Monday unwrapped enhancements to Physio-Control Inc., hoping to ignite a spark in its on again/off again defibrillator subsidiary. At the annual American Heart Association ...

Physio-Control Inc., the Redmond firm that makes Lifepak-brand defibrillators, plans to announce as early as today that it will lay off employees as it restructures to fix problems with its ...

REDMOND, Wash.--(BUSINESS WIRE)--Physio-Control has reached an agreement with HeartSine Technologies to acquire the Northern Ireland-based automated external defibrillator (AED) manufacturer, the ...

REDMOND, Wash.--(BUSINESS WIRE)--(Product Bulletin) Physio-Control announced today that the company is launching a voluntary field action for the LIFEPAK 1000 defibrillator due to reported instances ...

Physio-Control, a Redmond, Wash.-based provider of external defibrillators and emergency medical response products, recalled about 14,200 electrodes due to packaging issues, according to a Food and ...

Physio-Control Inc., the company that makes Lifepak brand defibrillators, confirmed Monday that it is on track to resume full shipments by April 30 and that it is making progress toward improving ...

Medtronic Inc., the world’s largest maker of heart-rhythm devices, agreed to sell its Physio-Control unit to Bain Capital LLC for $487 million in cash after saying in February it wanted to shed the ...